These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Scope and practicality of in vivo testing for adventitious agents. Whiteman MD Dev Biol (Basel); 2006; 123():147-52; discussion 183-97. PubMed ID: 16566442 [TBL] [Abstract][Full Text] [Related]
3. Laboratory host systems for extraneous agent testing in avian live virus vaccines: problems encountered. Philipp HC; Kolla I Biologicals; 2010 May; 38(3):350-1. PubMed ID: 20335050 [TBL] [Abstract][Full Text] [Related]
4. [Routine diagnosis of lymphocytic choriomeningitis in golden hamsters]. Rehman S; Wagner G Dtsch Tierarztl Wochenschr; 1972 Jul; 79(14):337-42. PubMed ID: 4564270 [No Abstract] [Full Text] [Related]
5. [Latent infection of the Syrian hamster (Mesocricetus auratus auratus) with lymphocytic choriomeningitis virus (LCM)]. Petrović M; Timm H Zentralbl Bakteriol Orig; 1968; 207(4):435-42. PubMed ID: 4987918 [No Abstract] [Full Text] [Related]
6. [Use of immunofluorescence in the routine diagnosis of lymphocytic choriomeningitis]. Förster U Zentralbl Veterinarmed B; 1973 Oct; 20(8):622-8. PubMed ID: 4588919 [No Abstract] [Full Text] [Related]
7. Issues of biological assays for viral vaccines. Lee CK Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161 [TBL] [Abstract][Full Text] [Related]
8. Implications, monitoring, and control of accidental transmission of lymphocytic choriomeningitis virus within hamster tumor cell lines. Biggar RJ; Deibel R; Woodall JP Cancer Res; 1976 Feb; 36(2 Pt 1):551-3. PubMed ID: 1260753 [No Abstract] [Full Text] [Related]
9. Envelope exchange for the generation of live-attenuated arenavirus vaccines. Bergthaler A; Gerber NU; Merkler D; Horvath E; de la Torre JC; Pinschewer DD PLoS Pathog; 2006 Jun; 2(6):e51. PubMed ID: 16751848 [TBL] [Abstract][Full Text] [Related]
10. CDC on the offensive to stamp out rodent virus. Nolen RS J Am Vet Med Assoc; 2006 Apr; 228(7):995-6. PubMed ID: 16579771 [No Abstract] [Full Text] [Related]
12. Insect cells as a new substrate for vaccine production. Dalemans W Dev Biol (Basel); 2006; 123():235-41; discussion 265-6. PubMed ID: 16566449 [TBL] [Abstract][Full Text] [Related]
13. Viral safety of biological products and the concept of validation. Horaud F Dev Biol Stand; 1996; 88():19-24. PubMed ID: 9119135 [No Abstract] [Full Text] [Related]
15. Molecular methods for virus discovery. Jarrett RF; Johnson D; Wilson KS; Gallagher A Dev Biol (Basel); 2006; 123():77-88; discussion 119-32. PubMed ID: 16566437 [TBL] [Abstract][Full Text] [Related]
16. Process evaluation for biopharmaceuticals: what is appropriate in process evaluation? Lubiniecki AS; McAllister PR; Smith TM; Shadle PJ Dev Biol Stand; 1996; 88():309-15. PubMed ID: 9119154 [No Abstract] [Full Text] [Related]
17. [Basic requirements of viral vaccines and methods for their control]. Osidse DF Arch Exp Veterinarmed; 1980; 34(1):123-6. PubMed ID: 6774690 [TBL] [Abstract][Full Text] [Related]
18. Lymphocytic choriomeningitis virus. A neglected pathogen of man. Jahrling PB; Peters CJ Arch Pathol Lab Med; 1992 May; 116(5):486-8. PubMed ID: 1316111 [No Abstract] [Full Text] [Related]
19. [Viral vaccines]. Morzycka M Pol Tyg Lek; 1971 Jan; 26(3):107-9. PubMed ID: 4925807 [No Abstract] [Full Text] [Related]
20. Multiplication of lymphocytic choriomeningitis virus in various systems. Simon M Acta Virol; 1970 Sep; 14(5):369-76. PubMed ID: 4394662 [No Abstract] [Full Text] [Related] [Next] [New Search]